Generic CellCept is used for preventing organ rejection following kidney, liver or heart transplants. This medicine is used in combination with other medicines. More info »
Rituximab Ineffective as Lupus Nephritis Add-On Therapy - Renal and Urology News
Rituximab Ineffective as Lupus Nephritis Add-On TherapyRenal and Urology NewsAdding rituximab to mycophenolate mofetil and corticosteroids does not improve outcomes in patients with lupus nephritis (LN), according to a study.
Myasthenia Gravis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 - MarketWatch (press release)
Myasthenia Gravis Therapeutics - Pipeline Assessment and Market Forecasts to 2019MarketWatch (press release).
Blistering Mucosal Eruption in a Young Woman With Systemic Lupus Erythematosus ... - Archives of Dermatology
Blistering Mucosal Eruption in a Young Woman With Systemic Lupus Erythematosus .
Stem Cell Therapy Safe in Macular Degeneration - MedPage Today
Zee NewsStem Cell Therapy Safe in Macular DegenerationMedPage TodayThey each had low-dose immunosuppression therapy with tacrolimus (Prograf) and mycophenolate mofetil (CellCept) starting a week before the procedure and continuing for six weeks afterward.
New Risk Factor Identified for PML With Natalizumab - Family Practice News Digital Network
New Risk Factor Identified for PML With NatalizumabFamily Practice News Digital Network.